EndoInSight is helping solve colorectal cancer by reducing pain and discomfort during colonoscopy procedures. Each year in the United States alone over 137,000 cases of colorectal cancer are diagnosed and over 50,000 Americans die from the disease. Although this disease is extremely deadly, it is also highly preventable through colonoscopy screenings. Our technology makes colonoscopy procedures more comfortable and less time consuming through its novel application of CO2 to inflate the colon. The use of CO2 during colonoscopy in lieu of ambient air offers the advantage of being absorbed directly into the body rather than remaining trapped in the patient’s bowel following the procedure. By leveraging single use technology EndoInSight provides medical facilities with the benefits of CO2 without the upfront capital expenses and cumbersome equipment associated with conventional systems.
Byron Smith, PhD